Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance

被引:485
作者
Wells, AD
Li, XC
Li, YS
Walsh, MC
Zheng, XX
Wu, ZH
Nuñez, G
Tang, AM
Sayegh, M
Hancock, WW
Strom, TB
Turka, LA [1 ]
机构
[1] Univ Penn, Dept Med, Philadelphia, PA 19104 USA
[2] Harvard Univ, Sch Med, Dept Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[3] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA
[4] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02142 USA
[5] LeukoSite Inc, Cambridge, MA 02142 USA
[6] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA
关键词
D O I
10.1038/15260
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mechanisms of allograft tolerance have been classified as deletion, anergy, ignorance and suppression/regulation. Deletion has been implicated in central tolerance(1), whereas peripheral tolerance has generally been ascribed to clonal anergy and/or active immunoregulatory states(2). Here, we used two distinct systems to assess the requirement for T-cell deletion in peripheral tolerance induction. in mice transgenic for Bcl-x(L), T cells were resistant to passive cell death through cytokine withdrawal, whereas T cells from interleukin-2-deficient mice did not undergo activation-induced cell death. Using either agents that block co-stimulatory pathways or the immunosuppressive drug rapamycin, which we have shown here blocks the proliferative component of interleukin-2 signaling but does not inhibit priming for activation-induced cell death, we found that mice with defective passive or active T-cell apoptotic pathways were resistant to induction of transplantation tolerance. Thus, deletion of activated T cells through activation-induced cell death or growth factor withdrawal seems necessary to achieve peripheral tolerance across major histocompatibility complex barriers.
引用
收藏
页码:1303 / 1307
页数:5
相关论文
共 24 条
  • [1] CD28 COSTIMULATION CAN PROMOTE T-CELL SURVIVAL BY ENHANCING THE EXPRESSION OF BCL-X(L)
    BOISE, LH
    MINN, AJ
    NOEL, PJ
    JUNE, CH
    ACCAVITTI, MA
    LINDSTEN, T
    THOMPSON, CB
    [J]. IMMUNITY, 1995, 3 (01) : 87 - 98
  • [2] Dai ZH, 1998, J IMMUNOL, V161, P1659
  • [3] BCL-X(L) DISPLAYS RESTRICTED DISTRIBUTION DURING T-CELL DEVELOPMENT AND INHIBITS MULTIPLE FORMS OF APOPTOSIS BUT NOT CLONAL DELETION IN TRANSGENIC MICE
    GRILLOT, DAM
    MERINO, R
    NUNEZ, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (06) : 1973 - 1983
  • [4] Gudmundsdottir H, 1999, J IMMUNOL, V162, P5212
  • [5] Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection
    Hancock, WW
    Sayegh, MH
    Zheng, XG
    Peach, R
    Linsley, PS
    Turka, LA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (24) : 13967 - 13972
  • [6] ANTIGEN PRESENTATION BY CHEMICALLY MODIFIED SPLENOCYTES INDUCES ANTIGEN-SPECIFIC T-CELL UNRESPONSIVENESS INVITRO AND INVIVO
    JENKINS, MK
    SCHWARTZ, RH
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (02) : 302 - 319
  • [7] NORMAL CLONAL EXPANSION BUT IMPAIRED FAS-MEDIATED CELL-DEATH AND ANERGY INDUCTION IN INTERLEUKIN-2-DEFICIENT MICE
    KNEITZ, B
    HERRMANN, T
    YONEHARA, S
    SCHIMPL, A
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (09) : 2572 - 2577
  • [8] Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
    Larsen, CP
    Elwood, ET
    Alexander, DZ
    Ritchie, SC
    Hendrix, R
    TuckerBurden, C
    Cho, HR
    Aruffo, A
    Hollenbaugh, D
    Linsley, PS
    Winn, KJ
    Pearson, TC
    [J]. NATURE, 1996, 381 (6581) : 434 - 438
  • [9] INTERLEUKIN-2 PROGRAMS MOUSE ALPHA-BETA-LYMPHOCYTES-T FOR APOPTOSIS
    LENARDO, MJ
    [J]. NATURE, 1991, 353 (6347) : 858 - 861
  • [10] LONG-TERM SURVIVAL OF XENOGENEIC PANCREATIC-ISLET GRAFTS INDUCED BY CTLA4IG
    LENSCHOW, DJ
    ZENG, YJ
    THISTLETHWAITE, JR
    MONTAG, A
    BRADY, W
    GIBSON, MG
    LINSLEY, PS
    BLUESTONE, JA
    [J]. SCIENCE, 1992, 257 (5071) : 789 - 792